- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1546-1696
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Facile repurposing of peptide–MHC-restricted antibodies for cancer immunotherapy ; day:2 ; month:1 ; year:2023 ; pages:1-12
Nature biotechnology ; (2.1.2023), 1-12
- Creator
-
Yang, Xinbo
Nishimiya, Daisuke
Löchte, Sara
Jude, Kevin M.
Borowska, Marta
Savvides, Christina S.
Dougan, Michael
Su, Leon
Zhao, Xiang
Piehler, Jacob
Garcia, K. Christopher
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41587-022-01567-w
- URN
-
urn:nbn:de:101:1-2023022121183710094093
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:46 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Yang, Xinbo
- Nishimiya, Daisuke
- Löchte, Sara
- Jude, Kevin M.
- Borowska, Marta
- Savvides, Christina S.
- Dougan, Michael
- Su, Leon
- Zhao, Xiang
- Piehler, Jacob
- Garcia, K. Christopher
- SpringerLink (Online service)
Other Objects (12)
Repurposing the yellow fever vaccine for intratumoral immunotherapy
Repurposing anti-mesothelin CAR-NK immunotherapy against colorectal cancer
Development of MHC-dependent immunotherapy for gliomas
Computational immunology : from MHC-peptide binding to immunotherapy
Facile synthetic entry into rotationally restricted 9-arylacridines
Enhanced presentation of MHC class Ia, Ib and class II-restricted peptides encapsulated in biodegradable nanoparticles: a promising strategy for tumor immunotherapy
Combination immunotherapy overcomes resistance in MHC class I-deficient cancer
Computational Methods to Find and Rank MHC-I Restricted Tumor-Associated Antigens to Improve Therapeutic Efficacy and Tolerability of Antigen-based Cancer Immunotherapy
The chaperones p97 and BAG6 in MHC class I-restricted antigen processing
T cell response to an MHC-II restricted epitope of rodent malaria
Drug repurposing
MHC-I genotype and tumor mutational burden predict response to immunotherapy
Repurposing the yellow fever vaccine for intratumoral immunotherapy
Repurposing anti-mesothelin CAR-NK immunotherapy against colorectal cancer
Development of MHC-dependent immunotherapy for gliomas
Computational immunology : from MHC-peptide binding to immunotherapy
Facile synthetic entry into rotationally restricted 9-arylacridines
Enhanced presentation of MHC class Ia, Ib and class II-restricted peptides encapsulated in biodegradable nanoparticles: a promising strategy for tumor immunotherapy
Combination immunotherapy overcomes resistance in MHC class I-deficient cancer
Computational Methods to Find and Rank MHC-I Restricted Tumor-Associated Antigens to Improve Therapeutic Efficacy and Tolerability of Antigen-based Cancer Immunotherapy
The chaperones p97 and BAG6 in MHC class I-restricted antigen processing
T cell response to an MHC-II restricted epitope of rodent malaria
Drug repurposing
MHC-I genotype and tumor mutational burden predict response to immunotherapy
Repurposing the yellow fever vaccine for intratumoral immunotherapy
Repurposing anti-mesothelin CAR-NK immunotherapy against colorectal cancer
Development of MHC-dependent immunotherapy for gliomas
Computational immunology : from MHC-peptide binding to immunotherapy
Facile synthetic entry into rotationally restricted 9-arylacridines
Enhanced presentation of MHC class Ia, Ib and class II-restricted peptides encapsulated in biodegradable nanoparticles: a promising strategy for tumor immunotherapy
Combination immunotherapy overcomes resistance in MHC class I-deficient cancer
Computational Methods to Find and Rank MHC-I Restricted Tumor-Associated Antigens to Improve Therapeutic Efficacy and Tolerability of Antigen-based Cancer Immunotherapy
The chaperones p97 and BAG6 in MHC class I-restricted antigen processing
T cell response to an MHC-II restricted epitope of rodent malaria
Drug repurposing